Objective: Congestive heart failure and other cardiac complications are the most important causes of death in patients with beta Thalassemia major. Iron overloads and chronic anemia are the major causes of cardiac involvement. The purpose of this study was to evaluate the ability of echocardiographic systolic function for diagnosis of cardiac involvement in patients with Thalassemia major. Methods: This descriptive study was done on patients with Thalassemia major (Over 12 years old) who referred to Booali Sina hospital in Sari. They were evaluated according to their ages, sex, age at beginning of transfusion of deferoxamine, the amount of deferoxamine, serum ferritin level, clinical manifestations, electrocardiogram, chest radiography and ...
Introduction: Cardiac complications, including heart failure, are the most important secondary ones ...
78 p.Thalassaemia is the haematological genetic disorder due to impaired haemoglobin synthesis. Alth...
Abstract Background and Objective: Many thalassemia patients don't have any symptoms until the dise...
Introduction : Patients with major thalassemia need recurrent transfusions and if not treated are at...
Background: Thalassemias constitute a group of chronic, inherited anemias that are transfusion depen...
Background- Cardiac involvement which leads to congestive heart failure (CHF) is a major cause of de...
Background- Cardiac involvement is one of the most common causes of morbidity and mortality in patie...
Background Thalassemia major (TM) is a transfusion-depen- dent disease. Multiple transfusions cause ...
Inroduction: Heart failure (HF) is an important cause of morbidity and mortality in the cases of B...
Objective: The objective of this study is to study the cardiovascular complications and to establish...
Cardiac complications are the leading cause of death in β-thalassemia major (TM) patients. The aim o...
Background and objective: One of the chief causes of death in patients with beta-thalassemia major (...
<p><strong>Introduction: </strong>There are more than 18000 thalassemia patients in Iran. In a curre...
Background: Cardiac dysfunction remains the major cause of death in beta-thalassemia. Aim of this st...
Objective: Beta-thalassemia major (TM) is a genetic hemoglobin disorder causing chronic hemolytic an...
Introduction: Cardiac complications, including heart failure, are the most important secondary ones ...
78 p.Thalassaemia is the haematological genetic disorder due to impaired haemoglobin synthesis. Alth...
Abstract Background and Objective: Many thalassemia patients don't have any symptoms until the dise...
Introduction : Patients with major thalassemia need recurrent transfusions and if not treated are at...
Background: Thalassemias constitute a group of chronic, inherited anemias that are transfusion depen...
Background- Cardiac involvement which leads to congestive heart failure (CHF) is a major cause of de...
Background- Cardiac involvement is one of the most common causes of morbidity and mortality in patie...
Background Thalassemia major (TM) is a transfusion-depen- dent disease. Multiple transfusions cause ...
Inroduction: Heart failure (HF) is an important cause of morbidity and mortality in the cases of B...
Objective: The objective of this study is to study the cardiovascular complications and to establish...
Cardiac complications are the leading cause of death in β-thalassemia major (TM) patients. The aim o...
Background and objective: One of the chief causes of death in patients with beta-thalassemia major (...
<p><strong>Introduction: </strong>There are more than 18000 thalassemia patients in Iran. In a curre...
Background: Cardiac dysfunction remains the major cause of death in beta-thalassemia. Aim of this st...
Objective: Beta-thalassemia major (TM) is a genetic hemoglobin disorder causing chronic hemolytic an...
Introduction: Cardiac complications, including heart failure, are the most important secondary ones ...
78 p.Thalassaemia is the haematological genetic disorder due to impaired haemoglobin synthesis. Alth...
Abstract Background and Objective: Many thalassemia patients don't have any symptoms until the dise...